Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Doctor training may boost shared decisions in cancer screening

NCT ID NCT06074536

Knowledge-focused Sponsor: CNGE Conseil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving general practitioners face-to-face training in patient-centered care helps them make better shared decisions with patients about colorectal cancer screening. About 400 patients aged 50 to 74 who are eligible for screening will take part. The main goal is to see if the training improves how much patients feel involved in the decision, measured by a questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
patient-centered approach training (face-to-face training for general practitioners)
What this could lead to
If successful, this could show that training doctors improves how patients and doctors make screening decisions together, potentially increasing screening rates.
What could go wrong
This is a relatively small trial (400 participants) testing a training method, not a new treatment. Results may not apply to other settings or screening programs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 74 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged 50 to 74: * Eligible for organized CRC screening, * Having declared as attending clinician a general practitioner investigator of the study ✓ Consulting their attending clinician for the duration of the study, * AND able and willing to comply with all trial requirements Non inclusion Criteria: \- ✓ Screened for CRC less than 2 years ago * Not eligible for organized CRC screening: * History of adenomas or CRC: \- Family (1st degree) * Personal history of IBD: * Crohn's disease * Ulcerative colitis) * Hereditary predispositions: * Familial adenomatous polyposis * Hereditary non-polyposis colorectal cancer (Lynch syndrome) * Patient with symptoms requiring colonoscopy * Having a level of literacy that does not allow the completion of the self-questionnaire. * Having an inability to give express consent. * Being under guardianship, curatorship or having cognitive disorders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer screening

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cabinet de groupe pluriprofessionnel

    RECRUITING

    Soisy-sous-Montmorency, 95230, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.